OBJECTIVE: To examine if there is a correlation between high blood glucose and serum ceruloplasmin (Cp) levels. RESEARCH DESIGN AND METHODS: Serum Cp levels were measured in 637 patients with type 2 diabetes (all type 2 diabetes group). For the follow-up type 2 diabetes group, 161 patients who had not had any changes in their situation during the last year that are known to influence serum Cp levels were reexamined 1 year later. The control group was composed of 158 healthy individuals. Serum Cp and blood HbA1c levels were measured by radial immunodiffusion and high-performance liquid chromatography assays, respectively. RESULTS: Serum Cp levels in the all type 2 diabetes group were significantly higher than those in the control group (P < 0.0001), although the serum Cp levels did not correlate with the blood HbA1c levels in the all type 2 diabetes group (r = 0.055, P = 0.351). Then we evaluated those factors (delta-log Cp and delta-HbA1c) in the follow-up type 2 diabetes group to minimize changes from the genetic differences and to exclude any known factors influencing serum Cp levels. This indicated that the delta-HbA1c had a positive correlation to the delta-log Cp (r = 0.304, P < 0.0001). CONCLUSIONS: A persistent high blood glucose (namely HbA1c) is associated with an increase in serum Cp levels over 1 year.
OBJECTIVE: To examine if there is a correlation between high blood glucose and serum ceruloplasmin (Cp) levels. RESEARCH DESIGN AND METHODS: Serum Cp levels were measured in 637 patients with type 2 diabetes (all type 2 diabetes group). For the follow-up type 2 diabetes group, 161 patients who had not had any changes in their situation during the last year that are known to influence serum Cp levels were reexamined 1 year later. The control group was composed of 158 healthy individuals. Serum Cp and blood HbA1c levels were measured by radial immunodiffusion and high-performance liquid chromatography assays, respectively. RESULTS: Serum Cp levels in the all type 2 diabetes group were significantly higher than those in the control group (P < 0.0001), although the serum Cp levels did not correlate with the blood HbA1c levels in the all type 2 diabetes group (r = 0.055, P = 0.351). Then we evaluated those factors (delta-log Cp and delta-HbA1c) in the follow-up type 2 diabetes group to minimize changes from the genetic differences and to exclude any known factors influencing serum Cp levels. This indicated that the delta-HbA1c had a positive correlation to the delta-log Cp (r = 0.304, P < 0.0001). CONCLUSIONS: A persistent high blood glucose (namely HbA1c) is associated with an increase in serum Cp levels over 1 year.
Authors: Chris J Sullivan; Thomas H Teal; Ian P Luttrell; Khoa B Tran; Mette A Peters; Hunter Wessells Journal: Physiol Genomics Date: 2005-08-23 Impact factor: 3.107
Authors: Francesco Piacenza; Marco Malavolta; Andrea Basso; Laura Costarelli; Robertina Giacconi; Eric Ravussin; Leanne M Redman; Eugenio Mocchegiani Journal: J Nutr Biochem Date: 2015-05-06 Impact factor: 6.048
Authors: Douglas Ganini; Donatella Canistro; JinJie Jiang; JinJie Jang; Krisztian Stadler; Ronald P Mason; Maria B Kadiiska Journal: Free Radic Biol Med Date: 2012-07-21 Impact factor: 7.376
Authors: Heather D VanGuilder; Georgina V Bixler; Lydia Kutzler; Robert M Brucklacher; Sarah K Bronson; Scot R Kimball; Willard M Freeman Journal: PLoS One Date: 2011-01-13 Impact factor: 3.240
Authors: Yang Zhao; Man Wang; Bo Meng; Ying Gao; Zhichao Xue; Minjun He; You Jiang; Xinhua Dai; Dan Yan; Xiang Fang Journal: Front Chem Date: 2021-06-11 Impact factor: 5.221